ALPS logo

ALPS GROUP INC

ALPSNASDAQ
๐Ÿ† #3560 by market capUS Equity
$0.41โ–ผ $0.01 (โˆ’2.88%)
๐ŸŒ… Pre-market$0.39โ–ผ 3.68%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ผ 2.9%
7dโ–ฒ 4.4%
14dโ–ผ 13.5%
30dโ–ผ 27.0%
1yโ€”
๐ŸฆMarket Cap
$70M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
โ€”
๐Ÿ“ŠGross Margin
โ€”
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
โ€”
Otter Score
45
Weak

Trading Snapshot

Day Range
$0.40 โ€“ $0.41
52-Week Range
$0.38 โ€“ $15.00
Volume
$3.27B
Avg Volume
$3.30B
Shares Outstanding
172.4M
Next Earnings
Oct 5, 2026

Fundamentals Snapshot

Annual Revenue
$3M
Last Q Revenue
$929,394
P/E Ratio
โ€”
P/S Ratio
โ€”
EPS (TTM)
โ€”
Dividend Yield
โ€”

Why Investors Own ALPS

  • โœ“High-growth profile โ€” revenue up -7.4% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 26% gross margin and 13% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$3Mโ–ผ โˆ’10.0% YoY
Gross Margin (TTM)
26.1%โ–ฒ +3.2% YoY
Operating Income (TTM)
$347,217โ–ผ โˆ’10.0% YoY
Free Cash Flow (TTM)
$434,864โ–ผ โˆ’10.0% YoY

About ALPS GROUP INC

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
45/100

Analyst Price Target

โ“˜
Average Target
$0.48
โ–ฒ +17.9% Upside
High Target$0.54
Low Target$0.45
Based on 28 analysts

Latest News & Updates